R. Catane

An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.

B. Chertin, A. Young, N. Algur, 2000, The Journal of urology.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

S. Paluch-Shimon, B. Kaufman, Y. Cohen, 2014, Fertility and sterility.

Estimation of creatinine clearance without 24-hour urine collection--a useful guide during cisplatin therapy.

S. Oman, N. Galai, N. Haim, 1993, Acta oncologica.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

S. Paluch-Shimon, B. Kaufman, Y. Cohen, 2014, Fertility and sterility.